Management of locally advanced prostate cancer 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999

World Journal of Urology

Volumn 18, Issue 3, 2000, Pages 204-215

  Schröder, Fritz H ^a   Van Ouden, Dies Den ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; BLOOD; CANCER STAGING; DISEASE COURSE; FORECASTING; HUMAN; MALE; MORTALITY; PATHOLOGY; POSTOPERATIVE CARE; PROSTATE TUMOR; REVIEW; SURVIVAL RATE; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FORECASTING; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0034207943     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003459900103     Document Type: Article

References (83)

1. Adolfsson J, Steineck G, Hedlund PO (1999) Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term follow-up. J Urol 161: 505-508
2. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280: 975-980
3. Ami Sidi A, Lange PH (1987) Adjuvant radiation therapy in patients upstaged to stage C or Dl disease after radical prostatectomy. Eur Urol 13: 238-241
4. Anscher MS, Prosnitz LR (1987) Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138: 1407-1412
5. Bagshaw MA, Cox RS, Ramback JE (1990) Radiation therapy for localised prostate cancer: justification by long-term followup. Urol Clin North Am 17: 787-802
6. Bagshaw MA, Cox RS, Hancock SL (1994) Control of prostate cancer with radiotherapy: long-term results. J Urol 152: 17811785
7. Belt E, Schröder FH (1972) Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91-96
8. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Stomre G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997). Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337: 295-300
9. Bolla M, Collette L, Gonzalez D, Warde P, Dubois JB, Mirimanoff R, Storme G, Bernier J, Kuten A. Piérart M (1999) Long term results of immediate adjuvant hormone therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy - a phase III EORTC study. Eur J Cancer 35 [Suppl 4]: 82
10. Boxer RJ, Kaufman JJ, Goodwill WE (1977) Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patients. J Urol 117: 208-213
11. Carter GE, Lieskovsky G. Skinner DG. Petrovitch Z (1989) Results of local and/or systemic adjuvant therapy in the management of pathologic stage C or Dl prostate cancer following radical prostatectomy. J Urol 142: 1266 1271
12. Cheng WS, Frydenberg M." Bergstralh E.I. Larson-Keller ,!J, Zincke H (1993) Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 42: 283 291
13. Conant JK, Flannery JT. Graydon RJ. Ely MG. Berlin BB (1985) Survival with localised carcinoma: radical prostatectomy versus radiation therapy. Urology 25: 347 349
14. DelRegato JA. Trailins AH, Pittman DD (1993) Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiât Oncol Biol Phys 26: 197 201
15. Eisbruch A, Ferez ÇA, Roessler EH. Locke MA (1994) Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 73: 384-387
16. Epstein JE (1990) Evaluation of radical prostatectomy capsular margins of resection: the significance of margins designated as negative, closely approaching and positive. Am J Surg Pathol 14: 626-632
17. Fair WR, Aprikian A, Sogani P, Reuter V, Whitmore WF (1993) The role of neoadjuvant hormone manipulation in localised prostatic cancer. Cancer 71: 1031 1038
18. Fellows GJ, Clark PB, Beynon LL, Boreham J, Keen C, Parkinson MC, Peto R, Webb JN (1992) Treatment of advanced prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council study. Br J Urol 70: 304-309
19. Flamm J, Fisher M, Holz W, Pfluger H, Tomschi W (1991) Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate. Eur Urol 19: 192-195
20. Forman JD, Wharam MD, Lee DJ, Zinreich ES, Order SE (1986) Definitive radiotherapy following prostatectomy: results and complications. Int J Radiât Oncol Biol Phys 12: 185-189
21. Fowler JE, Brasswell NT, Pandey P, Seaver L (1995) Experience with radical prostatectomy and radiation therapy for localised prostate cancer at a Veterans Affairs medical center. J Urol 153: 1026-1031
22. Freeman JA, Lieskovsky G, Cook DW, Petrovich Z, Chen S, Groshen S, Skinner DG (1993) Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (pCNO) prostate cancer from 1976 to 1989: intermediate findings. J Urol 149: 1029-1034
23. Fried PR, Mandell SA (1988) Role of adjuvant radiotherapy following radical prostatectomy for microscopic residual disease. Eur Urol 15: 37-39
24. Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, Hilaris BS, Whitmore WF (1991) The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with I25I-implantation. Int J Radiât Oncol Biol Phys 21: 537-547
25. Gibbons RP (1993) Localised prostate carcinoma, surgical management. Cancer 72: 2865-2872
26. Gibbons RP, Cole BS, Richardson RG, Correa RJ, Brannen GE, Mason JT, Taylor WJ, Hafermann MD (1986) Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135: 65-68
27. Gospodarowicz M, Warde P, Catton C, Crook J, Milosevic M, McLean M, Catton P (1999) Advances in radiotherapy of localized prostate cancer: improved effectiveness? In: Kurth KH, Mickisch GH, Schröder FH (eds) Renal, bladder and prostate cancer - an update. Proceedings of the 5th congress on progress and controversies in oncological urology (PACIOU V). Rotterdam, October 1998, ch 18. Parthenon. London New York, pp 147-157
28. Hanks GE (1988) Radical prostatectomy or radiation therapy for early prostate cancer: two roads to the same end. Cancer 61: 2153-2160
29. Hanks GE (1993) Treatment of early stage prostate cancer: radiotherapy. In: Hellman S, et al (eds) Important advances in oncology. Lippincott, Philadelphia, pp 225 239
30. Hanks GE. Dawson AK (1986) The role of external beam radiation therapy after prostatectomy for prostate cancer. Cancer 58: 2406-2410
31. Hawkins CA, Bergstrahl EJ, Lieber MM. Zincke H (1995) Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (pT3) prostate cancer after radical retropubic prostatectomy. Urology 46: 356 364
32. Hellström M, Haggman M, Brandstedt S, Torre M de la, Pedersen K. Jarlsfeldt I, Wijkstrom H. Busch C (1993) Hislopathological changes in androgen-deprived localised prostatie cancer. Eur Urol 24: 461 465
33. Hellström M, Haggman M. Pedersen K, Busch C, Brandstedt S (1999) A 3-year follow-up of patients with localised prostate cancer operated on with or without pre-treatment with the GnRH-agonist triptoreline. Br J Urol (in press)
34. Holzman M, Carlton CE, Scardino PT (1991) The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 146: 1578-1582
35. Kaplan ID, Prestidge BR, Bagshaw MA, Cox RS (1992) The importance of local control in the treatment of prostatie cancer. J Urol 147: 917-921
36. Kennedy TJ, Sonneland AM, Marlett MM. Troup RH (1992) Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer. J Urol 147: 891-893
37. Klotz LH, Goldenberg LS, Bullock MJ, Srigley JR. Lapalante S (1996) Neoadjuvant cyproterone acetate (CPA) therapy prior to radical prostatectomy reduces tumor burden and margin positivity without altering 6 and 12 months post-treatment PSA: results of a randomized trial (abstract 356). J Urol 155 [Suppl]: 399A
38. Klotz LH. Goldenberg SL. Jewett M, Barkin J, Chetner M, Fradet Y, Chin J, Laplante S (1999) CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologie Oncology Group. Urology 53: 763-767
39. Kuban DA, El Mahdi AM, Schellhammer P (1992) The significance of irradiation prostatie biopsy with long-term followup. Int J Radiât Oncol Biol Phys 24: 409-414
40. Kurth KH, Altwein JE, Skoluda D, Hohenfellner R (1977) Follow-up of irradiated prostatie carcinoma by aspiration biopsy. J Urol 117: 615-617
41. Kwon ED, Loening SA. Hawtrey CE (1991) Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, Bl and B2 cancer of the prostate. J Urol 145: 524-531
42. Labrie F, Cusan L, Gomez J, Diamond P, Suburk R, Lemay M, Tetu B, Fradet Y, Candas B (1994) Downstaging of early stage prostate cancer before radical prostatectomy: the first randomised trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist. Urology 44: 29- 37
43. Lange PH, Moon TD, Narayan P, Medini E (1986) Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results. J Urol 136: 45-4-9
44. Lange PH, Lightner DJ, Medini E, Reddy PK, Vessella RL (1990) The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144: 927-933
45. Laverdiere J, Gomez JL, Cusan L, et al (1997) Beneficial effect of combination hormone therapy administered prior to and following external beam radiation therapy in localized prostate cancer. Int J Radiât Oncol Biol Phys 37: 247-252
46. Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z (1994) Three dimensional conformai radiotherapy in localised carcinoma of the prostate: interim report of a phase I dose escalation study. J Urol 152: 1792-1798
47. Lerner SE. Blute ML, Zincke H (1995) Extended experience with radical prostatectomy for clinical stage T3 prostate can-cer: outcome and contemporary morbidity. J Urol 154: 14471452
48. Link P. Freiha FS. Stanley TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532-534
49. McCarthy JF, Catalona WJ, Hudson MA (1994) Effect of radiotherapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J Urol 151: 1575-1578
50. Medical Research Council Prostate Cancer Working Party Investigators Group (1997) Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 79: 235-246
51. Menon M. Parulkar BG, Baker S (1995) Should we treat localised prostate cancer? An opinion. Urology 46: 607-616
52. Morgan WR, Myers RP (1991) Endocrine therapy prior to radical retropubic prostatectomy for clinical stage C prostate cancer: pathologic and biochemical response (abstract 414). J Urol 145: 316
53. Olsson CA. Babayan R. DeVere White R (1985) Surgical management of stage B or C prostatic carcinoma: radical surgery vs radiotherapy. Urology 25: 30 35
54. Ouden D van den, Davidson PJT. Hop W, Schröder FH (1994) Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol 151: 646-651
55. Partin AW. Rattan MW, Subong ENP. Walsh PC, Wojno KJ, Oesterling JE. Scardino PT, Pearson JD (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 277: 1445 1451
56. Paulson DF, Hodge GB, Hinshaw W, the Uro-Oncology Research Group (1984) Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate. J Urol 131: 901-902
57. Paulson DF. Moul JD. Robertson JE, Walther PJ (1990) Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and or penetration through the capsule. J Urol 143: 1178-1182
58. Perez CA, Lee HK, Georgiou A, Logsdon MD, Lai PP, Locken MA (1993) Technical and tumor related factors affecting outcome of definitive irradiation for localised carcinoma of the prostate. Int J Radial Oncol Biol Phys 26: 581-591
59. Pilepich MV, Walz B.I. Baglan RJ (1984) Postoperative irradiation in carcinoma of the prostate. Int J Radiât Oncol Biol Phys 10: 1869-1873
60. Pilepich MV. Caplan R. Al-Sarraf M, John M, Dogger RLS. Sause WT, Lawlon CA, Abrams RA. Rotman M, Rubin P. Shipley WU, Cox JD (1993) Phase III trial of hormonal cytoreduction in conjunction with definite radiotherapy in locally advanced prostatic carcinoma: the emerging role of PSA in the assessment of outcome. Int J Radiât Oncol Biol Phys 27: 246
61. Pilepich MV. Caplan R, Byhardt RW, et al (1997) Phase III trial of androgen suppression using goserelin in unfavorableprognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group protocol 85-31. J Clin Oncol 15: 1013 1021
62. Porter AT, Forman JD (1994) The role of radiotherapy in the management of locally advanced prostate cancer. Urology 44: 43-46
63. Prestidge BR, Prête JJ. Buchholz TA. et al (1998) A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiât Oncol Biol Phys 40: 461-465
64. Pummer K. Crawford ED. Daneshgari F, Andros B. Pfister S, Miller GJ (1994) Hormone pre-treatment does not affect the final pathologic staue in locally advanced prostate cancer. Urology 44: 38 42
65. Rannikko S. Salo JO (1990) Radical prostatectomy as treatment of localised prostatic cancer. Scand J Urol Nephrol 24' 103 107
66. Rietbergen JBW, Hoedemaeker RF, Boeken Kruger AE. Kirkels WJ, Schröder FH (1999) The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen-detected prostate cancers in a population-based screening study. J Urol 161: 1192-1198
67. Rosen EM. Cassady JR, Conolly J, Chaffey JT (1984) Radiotherapy for localised prostate carcinoma. Int .1 Radiât Oncol Biol Phys 10: 2201-2210
68. Scardino PT, Frankel JM, Wheeler TM. Meacham RB, Huffman GS, Scale C, Wilbanks JH, Easley J, Carlton CE (1986) The prognostic significance of post-irradiation biopsy in patients with prostatic cancer. J Urol 135: 510 514
69. Schellhammer PF. Schlossberg S M. El Mahdi AM. Wright GL, Brassil DN (1991) Prostate spécifie antigen levels after definitive irradiation for carcinoma of the prostate. J Urol 145: 1008-1011
70. Schröder FH (1999) EORTC study 30846 - early versus delayed endocrine treatment in N+ prostate cancer. Oral Communication
71. Schulman CC (1994) Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review. Prostate 5 [Suppl]: 9-14
72. Scott WW. Boyd HL (1969) Combined hormone control, therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Urol 101: 86-92
73. Shevlin BE, Mittal BB, Brand WN, Shetty RM (1989) The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiât Oncol Biol Phys 16: 1425-1430
74. Soloway MS. Sharifi R. Wajzman Z, McLeod D. Wood D. Puras-Baez A (1996) Randomized prospective study - radical prostatectomy preceded by androgen blockade in cT2b prostate cancer initial results (abstract 976). J Urol 155 [Suppl]: 555A
75. Stamey TA, Kabalin JN, Ferrari M (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J Urol 141: 1084 1087
76. Terhorst B, Friedrichs R (1990) Frühergebnisse nach radikaler Prostatektomie bei Patienten mit Kapseldurchbruch, Samenblaseninfiltration und Mikrometastasen. Urologe 29: 91-95
77. Thompson IM, Löwe BA. Caroll PR. Narayan P (1991) A multi-center study of hormonal 'downstaging' of clinical stage C carcinoma of the prostate followed by radical prostatectomy (abstract 413). J Urol 145: 316
78. Walsh PC (1987) Adjuvant radiotherapy after radical prostatectomy: is it indicated? J Urol 138: 1427-1428
79. Watson R, Soloway MS (1996) Is there a role for induction androgen deprivation prior to radical prostatectomy? Hematol Oncol Clin North Am 10: 627-641
80. Witjes WP. Schulman CC. Debruyne FM (1997) Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormone combination therapy in T2-3 NO MO prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer. Urology 49 [Suppl 3A[: 65-69
81. Zagars GK. Eschenbach C, Ayala AG von (1993) Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer 72: 1709-1725
82. Zietman AL. Nakfoor BM, Prince EA, et al (1997) The effect of androgen deprivation and radiation therapy on an androgen-sensitive murine tumor: an in vitro and in vivo study. Cancer J Sei Am 3: 31- 36
83. Zincke H. Oesterling JE, Blute ML, Bergstralh EJ. Myers RP, Barrett DM (1994) Long-term (15 years) results after radical prostatectomy for clinically localised (stage T2c or lower) prostate cancer. J Urol 152: 1850 1857